To compare monopolar (MP) and bipolar (BP) diffusion weighted imaging (DWI) in detecting small liver metastases.
School of Medicine, Kyoto, Japan from January 2011 to October 2012. This retrospective study was performed in accordance with the Declaration of Helsinki (7) and approved by the local ethics committee. All patients provided informed written consent to undergo imaging examinations. Of the 88 patients, 65 were excluded as follows: concurrent chemotherapy (one patient); absent histological diagnosis and follow-up confirmation (two patients); lesions greater than 2 cm (seven patients); greater than five lesions, which can potentially be misdiagnosed as hepatic metastases (14 patients); and no hepatic metastasis (41 patients). The remaining 23 patients (16 men and 7 women, aged 41-82 years, mean age: 67 years) were included in the final analysis comprising 17 patients with colorectal cancer, four with pancreatic cancer, one with gastric cancer, and one with breast cancer.
Lesion diagnosis
Fifteen patients underwent definitive surgery with intraoperative ultrasonography (US), and 31 small hepatic metastases were histologically confirmed in these patients. In eight patients without a histopathologic diagnosis, the 15 visible small hepatic tumours were considered metastatic based on tumour growth observed at follow-up imaging examinations 3-20 months after the initial MRI. Tumour growth was defined according to Response Evaluation Criteria in Solid Tumours (RECIST) (8). Hepatic cirrhosis was not observed in any patient. The presence or absence of hepatic metastases was diagnosed by consensus between two radiologists (R.Y. and H.I., with 8 and 24 years' experience respectively, in gastrointestinal and hepatobiliary imaging) evaluating contrast-enhanced CT, US, positron emission tomography (PET) using F-18 fluorodeoxyglucose (FDG), and MRI; follow-up US, CT, FDG-PET, or MRI; and intraoperative US and serological examination. A total 46 small hepatic metastases (range: 0.3-2.0 cm; mean: 1.04 cm) in 23 patients were confirmed; five patients who did not have focal hepatic metastasis served as the control group (Table 1) . Of the 23 patients, eight had solitary lesions, 10 had two lesions, and the remaining five had three or more lesions (three had three lesions, one had four lesions, and one had five lesions).
Imaging protocols
All MRI examinations were performed using a commercially available 3-T MR system (MAGNETOM Skyra; Siemens AG, Healthcare Sector, Erlangen, Germany) equipped with a spine matrix coil and body matrix coil. DWI using a single-shot spin- GRAPPA factor = 2) was acquired between the dynamic and hepatocyte phases using Gd-EOB-DTPA (Fig.1) . In this study, apparent diffusion coefficient (ADC) measurement was not because it fell outside the remit of this study.
Imaging analysis

Quantitative Evaluation
Quantitative evaluations were performed by a radiologist (A.F. with 12 years' experience). Regions of interest (ROIs) were centred on the focal lesion and hepatic parenchyma using a commercially available DICOM viewer (YAKAMI Software, Kyoto, Japan) to measure signal intensity (SI) on DWI with a b-value = 1,000 s/mm 2 .
The ROI was constructed to maximally encompass the lesion while avoiding necrotic cystic regions at identical sites on MP and BP sequences. Because a parallel imaging technique was employed, the background noise standard deviation (SD)
could not be used to calculate the image signal-to-noise ratio (SNR); therefore, SD of the normal liver SI adjacent to the lesion was used estimate local noise (9-11). The ROI was centred in the adjacent liver parenchyma measuring at least 100 mm 2 and residing in a homogeneous portion devoid of vessels and prominent artefacts. The contrast-to-noise ratio (CNR) between the corresponding liver lesion and liver parenchyma, and the liver parenchyma or lesion SNR were calculated as follows:
CNR= (SIL -SIP)/ noise, SNRparenchyma or lesion = (SIp or SlL)/ noise where the liver parenchyma signal intensity is SIP and the corresponding lesion signal intensity is SIL. The CNR and SNR at an undetectable lesion were scored zero and one, respectively.
Qualitative Evaluation
The two patient groups (MP and BP sequences) were statistically compared. Three readers (T.O., H.S., and S.K. with 8, 10, and 10 years' experience, respectively, in gastrointestinal and hepatobiliary imaging) who were not the two diagnostic radiologists interpreted the images independently. The readers were aware of the hepatic metastasis risk but were blinded to all other historical information including the primary tumour site. All data were anonymised and randomised. Image analysis was performed on a DICOM viewer in two sessions at a 4-week interval to minimise any learning bias. Each observer recorded the presence and segmental location of the lesions based on a 5-point confidence scale: 1 = definitely not present; 2 = probably not present; 3 = equivocal; 4 = probably present; and 5 = definitely present.
To accurately correlate the scored lesions and gold standard findings, each observer recorded the individual image number, segmental location, and lesion size. In single segments containing multiple lesions, the observers recorded the lesion size and location within each segment to avoid confusion during data analysis. In addition, a radiologist (A.F.) correlated the scored lesions to a reference standard based on the recorded lesion size and location
The lesion distortion score (LDS) was assessed by two radiologists (R.Y. and H.I.) on a four-point scale from 4 (minimal or no distortion) to 1 (excessive distortion) to
Discussion
Accurate detection of hepatic metastases, especially small lesions, is clinically important because it may significantly affect the therapeutic approach (12). MRI, especially single-shot EPI DWI, can obtain high lesion-to-liver contrast even without a contrast agent. Recently, abdominal DWI has become widely used in cancer patients because it provides additional information facilitating lesion detection, particularly for hepatic metastasis (13,14) . In this study, hepatic DWI was performed using two approaches: an MP sequence, which shortens the echo time, and a BP sequence, which reduces the eddy current.
The present study demonstrates that there is no significant difference in the liver parenchymal SNR between MP and BP sequences. Kyriazi et al. reported that the liver parenchymal SNR was lower using the BP sequence than the MP sequence (15), but our results are consistent with those of another study that reported no significant SNR difference between MP and BP sequences (5). Although the signal intensities of liver parenchyma with BP are lower than with MP, the reduced distortion in the 3-T system decreases noise during BP sequence compared to during MP sequence. Notably, the SNR of hepatic lesions were overall superior and the CNR significantly higher with the BP sequence. Potentially, the reduced distortion of BP decreased the noise compared MP despite the lowered signal intensities in the liver parenchyma and lesion, and the CNR of the BP sequence improved as a result.
The detection sensitivity of one reader was significantly higher with the BP sequence; the other two readers showed a higher detection sensitivity with the BP compared to the MP sequence, but without statistical significance. The present study also demonstrates that reading a BP sequence improves the eddy-current-induced image distortion in small liver metastases compared to the MP sequence. For the distortion analysis classified as no-distortion and distortion lesions by LDS, the nodistortion group detection sensitivities were significantly higher than in the distortion group, except in one reader with the MP sequence. This particular reader also had a higher detection sensitivity in the no-distortion than in the distortion group, but the difference was not significant. This result suggests that lesion distortion strongly influences the lesion detection sensitivity. Rosenkrantz et al. reported a higher sensitivity with reduced distortion DWI compared to DWI alone when detecting prostate cancer (16). In addition, the image quality of hepatic parenchyma in BP DWI is reportedly superior to that with the MP sequence by reducing the eddy-currentinduced distortion (15). However, an association between the lesion distortion in DWI and lesion detection sensitivity has not been previously reported. Presumably, the hepatic lesion distortion is reduced in the BP sequence compared to the MP sequence. This may explain the distortion at the tumour-parenchyma boundary causing blurring of the lesion shape; as a result, distorted lesions may be overlooked.
Chung et al. reported that the detection sensitivity of small liver metastases (≦2 cm) using DWI is lower compared to sensitivity in larger metastases (＞2 cm) (17).
Although the detection sensitivity was decreased by the eddy current induced artefact in the small liver metastases (≦2 cm) targeted in the present study, the eddyinduced distortion may not influence the detection sensitivity of larger lesions (＞2 cm).
The short liver T2 requires the diffusion-encoding gradients to be set at the shortest possible echo time. Also, because the liver is a relatively homogeneous abdominal organ, it was thought that liver metastases would not be easily influenced by the eddy current-induced distortion. Therefore, the detection sensitivity with MP was expected to be higher than with BP, but the opposite relationship was observed.
Other abdominal organs have a longer T2 and more heterogeneous parenchyma than the liver; therefore, the higher metastasis detection rate with BP may be similar in other organs.
Only one lesion on bipolar DWI was not detected due to physiologic and movement-related artefacts. The lesion was very small (7 mm diameter) and located in the superior lateral lobe. In this location, images can be markedly distorted by pulmonary and intestinal air, and signal loss may be caused by cardiac motion (18, 19 ). This may be observed only during MP because the SI of lesions were higher on MP sequence than on BP sequence.
The study had several limitations. Being a retrospective study with a small sample size, the data may have been influenced by selection and verification biases. Further prospective studies using a larger patient population are recommended to confirm the present findings. Furthermore, not all lesions were compared and confirmed with surgical specimens. However, lesions were diagnosed using a multi-modality imaging follow-up performed by two experienced readers, which limits the risk of misclassification. Notably, 14 patients with more than five focal hepatic lesions were excluded. A relatively large number of patients were excluded, potentially leading to selection bias. DWI was acquired after administering Gd-EOB-DTPA to shorten the examination time, and this may have affected the ADC values. However, a recent paper reported that ADCs of focal hepatic lesions were not significantly different before and after contrast administration, and DWI after Gd-EOB-DTPA administration can substitute for unenhanced DWI at 3.0 T without compromising the CNR and ADC of focal hepatic lesions (20). Finally, the hepatic lesion detection and characterisation ability of these DWI sequences was not compared to other sequences because the study only aimed to objectively compare the image quality between the two DWI sequences.
In conclusion, the BP DWI sequence reduced eddy current more than the MP DWI sequence and was acceptable in detecting small liver metastases because the detection sensitivity of small liver metastases is affected by eddy current-induced lesion distortion. where SIp is liver parenchyma signal intensity, and SIL is liver lesion signal intensity.
*Significant difference between MP and BP (P = 0.017).
Table 3
Detection sensitivity per-lesion in the three individual readers using BP and MP images. Table 4 Lesion distortion scores compared between BP and MP sequence groups α MP BP 2.80 ± 1.03 3.39 ± 0.87 P = 0.002* α Mean ± SD.
MP BP
*Indicates a significant difference. Table 5 Correlation between lesion distortion degree and detection sensitivity in BP and MP sequences.
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